Leland Gershell
Stock Analyst at Oppenheimer
(4.18)
# 517
Out of 4,412 analysts
79
Total ratings
32.47%
Success rate
30.85%
Average return
Main Sectors:
30 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TARA Protara Therapeutics | Maintains: Outperform | $26 → $30 | $2.93 | +925.64% | 2 | Apr 22, 2024 | |
| AVTX Avalo Therapeutics | Upgrades: Outperform | $35 | $15.94 | +119.57% | 2 | Apr 16, 2024 | |
| VERU Veru Inc. | Reiterates: Outperform | $7 → $5 | $1.27 | +293.70% | 5 | Apr 15, 2024 | |
| CUE Cue Biopharma | Maintains: Outperform | $10 | $1.37 | +632.60% | 1 | Apr 9, 2024 | |
| NCNA NuCana | Reiterates: Outperform | $4 | $4.00 | - | 5 | Apr 1, 2024 | |
| CALC CalciMedica | Maintains: Outperform | $14 | $5.45 | +156.88% | 4 | Apr 1, 2024 | |
| XERS Xeris Biopharma Holdings | Initiates: Outperform | $5 | $1.75 | +185.71% | 1 | Mar 28, 2024 | |
| IMVT Immunovant | Initiates: Outperform | $50 | $27.17 | +84.03% | 1 | Mar 28, 2024 | |
| CPRX Catalyst Pharmaceuticals | Reiterates: Outperform | $29 | $14.89 | +94.76% | 2 | Mar 27, 2024 | |
| TRVI Trevi Therapeutics | Maintains: Outperform | $9 | $2.78 | +223.74% | 2 | Mar 21, 2024 | |
| CRNX Crinetics Pharmaceuticals | Maintains: Outperform | $54 → $55 | $42.12 | +30.58% | 5 | Mar 20, 2024 | |
| URGN UroGen Pharma | Maintains: Outperform | $35 → $34 | $14.15 | +140.28% | 5 | Mar 15, 2024 | |
| LUMO Lumos Pharma | Maintains: Outperform | $16 | $2.77 | +477.62% | 4 | Mar 8, 2024 | |
| SLNO Soleno Therapeutics | Maintains: Outperform | $44 → $47 | $37.89 | +24.04% | 5 | Jan 2, 2024 | |
| VRDN Viridian Therapeutics | Maintains: Outperform | $35 → $36 | $12.88 | +179.50% | 3 | Dec 19, 2023 | |
| PDSB PDS Biotechnology | Maintains: Outperform | $23 → $20 | $3.27 | +511.62% | 3 | Nov 15, 2023 | |
| ALNY Alnylam Pharmaceuticals | Downgrades: Perform | n/a | $143.31 | - | 5 | Oct 11, 2023 | |
| MIST Milestone Pharmaceuticals | Maintains: Outperform | $16 → $13 | $1.54 | +744.16% | 3 | Apr 12, 2023 | |
| ASND Ascendis Pharma | Downgrades: Perform | n/a | $135.90 | - | 6 | Apr 5, 2023 | |
| XFOR X4 Pharmaceuticals | Maintains: Outperform | $5 → $4 | $1.17 | +243.35% | 1 | Mar 24, 2023 | |
| BMRN BioMarin Pharmaceutical | Downgrades: Perform | n/a | $80.91 | - | 2 | Feb 22, 2023 | |
| ARGX argenx SE | Initiates: Perform | n/a | $372.80 | - | 1 | Oct 12, 2022 | |
| CLNN Clene | Downgrades: Perform | n/a | $0.34 | - | 1 | Oct 4, 2022 | |
| ACST Acasti Pharma | Initiates: Outperform | $36 | $2.90 | +1,141.38% | 3 | Dec 22, 2021 | |
| WINT Windtree Therapeutics | Initiates: Outperform | n/a | $5.23 | - | 1 | Jun 4, 2021 | |
| TRVN Trevena | Initiates: Perform | n/a | $0.39 | - | 1 | Mar 15, 2021 | |
| TEVA Teva Pharmaceutical | Initiates: Perform | n/a | $13.81 | - | 1 | Nov 25, 2020 | |
| CASI CASI Pharmaceuticals | Initiates: Outperform | n/a | $2.42 | - | 1 | Oct 23, 2020 | |
| VCNX Vaccinex | Maintains: Outperform | $4,620 → $1,470 | $5.83 | +25,114.41% | 2 | Sep 25, 2020 | |
| AMRN Amarin Corporation | Upgrades: Perform | n/a | $0.87 | - | 1 | Mar 31, 2020 |
Protara Therapeutics
Apr 22, 2024
Maintains: Outperform
Price Target: $26 → $30
Current: $2.93
Upside: +925.64%
Avalo Therapeutics
Apr 16, 2024
Upgrades: Outperform
Price Target: $35
Current: $15.94
Upside: +119.57%
Veru Inc.
Apr 15, 2024
Reiterates: Outperform
Price Target: $7 → $5
Current: $1.27
Upside: +293.70%
Cue Biopharma
Apr 9, 2024
Maintains: Outperform
Price Target: $10
Current: $1.37
Upside: +632.60%
NuCana
Apr 1, 2024
Reiterates: Outperform
Price Target: $4
Current: $4.00
Upside: -
CalciMedica
Apr 1, 2024
Maintains: Outperform
Price Target: $14
Current: $5.45
Upside: +156.88%
Xeris Biopharma Holdings
Mar 28, 2024
Initiates: Outperform
Price Target: $5
Current: $1.75
Upside: +185.71%
Immunovant
Mar 28, 2024
Initiates: Outperform
Price Target: $50
Current: $27.17
Upside: +84.03%
Catalyst Pharmaceuticals
Mar 27, 2024
Reiterates: Outperform
Price Target: $29
Current: $14.89
Upside: +94.76%
Trevi Therapeutics
Mar 21, 2024
Maintains: Outperform
Price Target: $9
Current: $2.78
Upside: +223.74%
Crinetics Pharmaceuticals
Mar 20, 2024
Maintains: Outperform
Price Target: $54 → $55
Current: $42.12
Upside: +30.58%
UroGen Pharma
Mar 15, 2024
Maintains: Outperform
Price Target: $35 → $34
Current: $14.15
Upside: +140.28%
Lumos Pharma
Mar 8, 2024
Maintains: Outperform
Price Target: $16
Current: $2.77
Upside: +477.62%
Soleno Therapeutics
Jan 2, 2024
Maintains: Outperform
Price Target: $44 → $47
Current: $37.89
Upside: +24.04%
Viridian Therapeutics
Dec 19, 2023
Maintains: Outperform
Price Target: $35 → $36
Current: $12.88
Upside: +179.50%
PDS Biotechnology
Nov 15, 2023
Maintains: Outperform
Price Target: $23 → $20
Current: $3.27
Upside: +511.62%
Alnylam Pharmaceuticals
Oct 11, 2023
Downgrades: Perform
Price Target: n/a
Current: $143.31
Upside: -
Milestone Pharmaceuticals
Apr 12, 2023
Maintains: Outperform
Price Target: $16 → $13
Current: $1.54
Upside: +744.16%
Ascendis Pharma
Apr 5, 2023
Downgrades: Perform
Price Target: n/a
Current: $135.90
Upside: -
X4 Pharmaceuticals
Mar 24, 2023
Maintains: Outperform
Price Target: $5 → $4
Current: $1.17
Upside: +243.35%
BioMarin Pharmaceutical
Feb 22, 2023
Downgrades: Perform
Price Target: n/a
Current: $80.91
Upside: -
argenx SE
Oct 12, 2022
Initiates: Perform
Price Target: n/a
Current: $372.80
Upside: -
Clene
Oct 4, 2022
Downgrades: Perform
Price Target: n/a
Current: $0.34
Upside: -
Acasti Pharma
Dec 22, 2021
Initiates: Outperform
Price Target: $36
Current: $2.90
Upside: +1,141.38%
Windtree Therapeutics
Jun 4, 2021
Initiates: Outperform
Price Target: n/a
Current: $5.23
Upside: -
Trevena
Mar 15, 2021
Initiates: Perform
Price Target: n/a
Current: $0.39
Upside: -
Teva Pharmaceutical
Nov 25, 2020
Initiates: Perform
Price Target: n/a
Current: $13.81
Upside: -
CASI Pharmaceuticals
Oct 23, 2020
Initiates: Outperform
Price Target: n/a
Current: $2.42
Upside: -
Vaccinex
Sep 25, 2020
Maintains: Outperform
Price Target: $4,620 → $1,470
Current: $5.83
Upside: +25,114.41%
Amarin Corporation
Mar 31, 2020
Upgrades: Perform
Price Target: n/a
Current: $0.87
Upside: -